IMV TECHNOLOGIES acquired by QUALIUM
Context
Qualium Investissement won the auction process to acquire IMV Technologies, beating competitors LBO France and Florac. This transaction ends the tenure of Pragma Capital (majority owner since 2010), as well as minority investors Cathay Capital and Eurazeo PME. The acquisition is supported by a unitranche debt facility provided by Ardian, representing a leverage of over 5.0x EBITDA. The strategic focus remains on international expansion.
It is worth noting that the fund Sparring Capital took control of Imv Technologies through an LBO in 2010.
IMV TECHNOLOGIES, which reported an EBITDA margin of [members only] in 2013, is valued in this transaction at an EV/EBITDA multiple of 5x–12x, representing a discount to the average currently observed in the Healthcare & Pharma sector (14.3x).
-> Deep-dive in Healthcare & Pharma market trends
Target
IMV Technologies is the world leader in reproduction biotechnologies for livestock (primarily bovine and porcine). The company designs and manufactures equipment and consumables (plastic straws) for artificial insemination. It holds a dominant position with over 50% global market share in bovine packaging. 85% of its revenue is generated internationally across 120 countries.
Ent. Value
€100–350M
Equity Value
[members only]
Multiples
EV / Revenue
1x–3x
EV / EBITDA
5x–12x
EV / EBIT
[members only]
Historical Financials (EUR)
Other operations with IMV TECHNOLOGIES
Other operations with IMV TECHNOLOGIES
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 01/2021 | MONTAGU PRIVATE EQUITY | IMV TECHNOLOGIES | FRANCE | R&D Biotech |
| 09/2010 | SPARRING CAPITAL | IMV TECHNOLOGIES | FRANCE | R&D Biotech |
Similar deals in Life Sciences
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 06/2015 | WHITEWAVE | VEGA | CANADA | Nutrition & Dietary Supplements |
| 06/2015 | BC PARTNERS | PHARMATHEN | GREECE | CDMO |
| 11/2014 | PERRIGO COMPANY | OMEGA PHARMA | BELGIUM | Generics / Labs |
| 09/2014 | INSTITUT MERIEUX / SAGARD / SOFIPROTEOL | CEVA SANTE ANIMALE | FRANCE | Animal Health |
| 03/2014 | MONTAGU PRIVATE EQUITY | Arkopharma | FRANCE | Nutrition & Dietary Supplements |
| 02/2014 | MONTAGU PRIVATE EQUITY | NEMERA | FRANCE | Medical Consumables |
| 01/2014 | FIVE ARROWS | DUTSCHER | FRANCE | Medical Consumables |
| 10/2013 | ARDIAN | LABORATOIRES ANIOS | FRANCE | Medical Consumables |
| 07/2013 | CHARTERHOUSE | DOC GENERICI | ITALY | Generics / Labs |
| 06/2013 | EURAZEO | PÉTERS SURGICAL | FRANCE | Medical Consumables |
Other operations with QUALIUM
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 09/2025 | QUALIUM | GROUPE ALLEN | FRANCE | Wealth & Asset Management |
| 10/2024 | QUALIUM | IMPC (IMAGERIE MEDICALE PARIS CENTRE) | FRANCE | Radiology |
| 08/2019 | QUALIUM | ACOLAD | FRANCE | Document Management |
| 06/2019 | QUALIUM / BPIFRANCE | EMLYON | FRANCE | Education Providers |
| 01/2018 | QUALIUM | LABELIUM | FRANCE | AdTech |
| 10/2016 | QUALIUM | VULCANIC | FRANCE | Boilers & Thermal Solutions |
| 07/2008 | QUALIUM | SOCOTEC | FRANCE | TIC (Testing, Inspection, Certification) |
REFERENCES
Valuation range: EV €100–350M
Revenue range: €50–100M
EBITDA range: €5–25M
EV/Revenue range: 1x - 3x
EV/EBITDA range: 5x - 12x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of IMV TECHNOLOGIES by QUALIUM are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Press release: view release
Target: imv technologies
Acquirer: qualium